Cell Medica's Series B Round

Cell Medica raised a round of funding on July 23, 2012.

Cell Medica develops, manufactures and markets cellular immunotherapy products for the treatment of cancer and infections. The Company employs technologies to develop cell-based therapies with the pot…

Articles about Cell Medica's Series B Round: